# Medically Recommended Cannabis Use for US Adolescents. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medically-recommended-cannabis-use-adolescents/ > **Published:** 2026-03-29T08:02:33-04:00 | **Last Modified / Clinically Audited:** 2026-10-02T13:50:15-04:00 > **Clinical Summary:** Explore medically recommended cannabis use adolescents with data on prevalence, risks, and clinical implications from a national study. --- CED Clinical Relevance  #56Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch  |  CED Clinic Adolescent Medicine[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)[Cannabis Use Disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/)EpidemiologyPediatrics Journal American journal of preventive medicine Study Type Clinical Study Population Human participants Why This Matters This is the first nationally representative study to examine medically recommended cannabis use in US adolescents, providing critical baseline data as [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) programs expand. Understanding the prevalence and correlates of medical versus non-medical use in this vulnerable population informs clinical decision-making and policy development. Clinical Summary This cross-sectional analysis of 2021-2023 National Survey on Drug Use and Health data examined 3,906 adolescents aged 12-17 with past-year cannabis use. Among cannabis-using adolescents, 5.2% reported healthcare professional-recommended use. The study compared sociodemographic factors, [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) rates, and other substance use between medically recommended and non-medical users. Multivariable regression models assessed associations with cannabis use disorder and concurrent substance use, controlling for demographic variables. Dr. Caplan’s Take “While 5.2% may seem low, this represents thousands of adolescents receiving medical cannabis recommendations nationally. The critical question this study begins to address is whether medical recommendations alter risk profiles compared to non-medical use.” Clinical Perspective 🧠 Clinicians should recognize that medical cannabis use in adolescents is occurring in clinical practice, requiring evidence-based approaches to patient selection, monitoring, and risk mitigation. This data establishes baseline prevalence but clinicians need robust protocols for adolescent [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) given the developing brain’s vulnerability to cannabinoids. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Medically%20Recommended%20Cannabis%20Use%20for%20US%20Adolescents.%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41903661/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41903661/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Medically%20Recommended%20Cannabis%20Use%20for%20US%20Adolescents.%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41903661/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41903661/](https://pubmed.ncbi.nlm.nih.gov/41903661/) Table of Contents - [FAQ](#FAQ)[How common is medically recommended cannabis use among adolescents?](#How_common_is_medically_recommended_cannabis_use_among_adolescents) - [Does medical cannabis recommendation protect adolescents from developing cannabis use disorder?](#Does_medical_cannabis_recommendation_protect_adolescents_from_developing_cannabis_use_disorder) - [Should healthcare providers be concerned about other substance use in adolescents prescribed medical cannabis?](#Should_healthcare_providers_be_concerned_about_other_substance_use_in_adolescents_prescribed_medical_cannabis) - [What are the clinical implications for prescribing medical cannabis to adolescents?](#What_are_the_clinical_implications_for_prescribing_medical_cannabis_to_adolescents) - [How should this research influence clinical practice regarding adolescent medical cannabis?](#How_should_this_research_influence_clinical_practice_regarding_adolescent_medical_cannabis) - [Related](#Related) ## FAQ #### How common is medically recommended cannabis use among adolescents? Based on this nationally representative study, only 5.2% of adolescents who used cannabis in the past year reported that it was medically recommended by a healthcare professional. This represents a small fraction of overall [adolescent cannabis use](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/), suggesting most teen cannabis use remains non-medical. #### Does medical cannabis recommendation protect adolescents from developing cannabis use disorder? No, the study found no protective effect from medical recommendations. Adolescents using medically recommended cannabis had similar rates of cannabis use disorder compared to those using cannabis non-medically. This suggests medical recommendation alone does not prevent problematic use patterns in teens. #### Should healthcare providers be concerned about other substance use in adolescents prescribed medical cannabis? Yes, the study found that adolescents using medically recommended cannabis showed similar patterns of other substance use as those using cannabis non-medically. This indicates a need for comprehensive substance use screening and monitoring in adolescents receiving medical cannabis recommendations. #### What are the clinical implications for prescribing medical cannabis to adolescents? Healthcare providers should exercise extreme caution when considering medical cannabis for adolescents, as this study shows no reduction in addiction risk compared to non-medical use. Careful risk-benefit analysis, close monitoring, and consideration of [alternative treatments](https://cedclinic.com/citral-cannabinoid-receptor-2-activation-pain-relief/) should be prioritized given the developing adolescent brain’s vulnerability. #### How should this research influence clinical practice regarding adolescent medical cannabis? This early-stage evidence suggests that medical cannabis recommendations in adolescents may not provide the safety profile previously assumed. Clinicians should implement rigorous monitoring protocols and consider this data when weighing treatment options, though more research is needed before definitive practice changes. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Medically Recommended Cannabis Use for US Adolescents.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41903661/”, “about”: “american journal preventive medicine clinical study”, “isPartOf”: “American journal of preventive medicine”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Substance Use and Suicide Attempts in Adolescents](https://cedclinic.com/adolescent-substance-use-suicide-risk-analysis/) A comparative analysis of clinical and psychosocial risk factors related to adolescent substance use and suicide attempts. [Read More](https://cedclinic.com/adolescent-substance-use-suicide-risk-analysis/) [The Effect of Cannabis Use on Youth Affect](https://cedclinic.com/cannabis-effects-youth-daily-mood-patterns/) Study on how cannabis use influences the daily positive and negative emotional states of youth. [Explore Study](https://cedclinic.com/cannabis-effects-youth-daily-mood-patterns/) [Opioids and Cannabis: An Uncertain Combination?](https://cedclinic.com/opioid-cannabis-interactions-risks-clinical-insights/) Review of the complex interactions and risks of combining opioids with cannabis use. [Learn More](https://cedclinic.com/opioid-cannabis-interactions-risks-clinical-insights/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).